MedPath

Evaluating the efficacy of, integrated therapeutic measures on functional and psychological outcomes in athletes with iliotibial band syndrome; a Randomized Controlled study

Not Applicable
Recruiting
Conditions
iliotibial band syndrome
Registration Number
SLCTR/2021/032
Lead Sponsor
Teaching Hospital Karapitiya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

•Athletes who are diagnosed to have ITBS and who requires rehabilitation.
(diagnosis criteria for ITBS: The ailment is predominantly diagnosed on clinical grounds. Specific symptoms, signs and functional testing can detect the disorder with a significant accuracy. The characteristics of ITBS include number of clinical symptoms & signs found on patients having lateral knee pain. The classical sign of diagnosing ITBS is the point tenderness just proximal to Lateral femoral condyle (LFC).

Clinical history
a.Grade IGeneralized lateral knee ache after training, which resolves with rest.
b.Grade IISpecific lateral knee pain at end of training activity that usually resolves with rest and does not affect performance.
c.Grade IILateral knee pain at onset of activity that interferes with performance.
d.Grade IVLateral knee pain limits training and is felt during activities of daily living.

Physical examination – special tests
a.Positive Noble Compression Test (cardinal sign)
b.Positive Thomas Test
c.Positive Ober test
d.Positive Lateral step-down test

Case definition of ITBS diagnosis
Clinical history and four special tests must be positive for the confirmation of diagnosis

•Age >18 years and < 50 years
•Injury no more than three months old.
•Both male and female athletes

Exclusion Criteria

•Participants who are suspected to be having following conditions around knee,
Any old femur fracture, tibial fracture and chondromalacia patella, bilateral ITBFS,Malignancy,
Rheumatic arthritis, bleeding disorders, Acute skin infections
•Patients who have had any form of Mayo - Fascial Release (MFR) and or KT therapies within past two weeks.
•Known skin allergies to adhesive plaster or KT
•Participants who are having any contraindication for MT -
Total Contraindications (TC):Fever, Contagious diseases, Pain medication, pacemakers, Neuritis, Skin diseases/CellulitisRecent operations/ Haematoma, Acute injuries/FracturesHypersensitivity to touch,Under the influence of drugs or alcohol

Local Contraindications:
Varicose veins, Undiagnosed lumps or bumps, Pregnancy, Bruising Cuts, Abrasions, and Wounds, Sunburn, Undiagnosed pain, Inflammation, including arthritis
Medical Contraindications (MC):Thrombosis, PhlebitisHypertensionAngina, those with Psoriasis or EczemaOsteoporosisEpilepsy, Diabetes, Bell’s palsyOedemaGynecological infection

•Participants who are having any significant conditions including medical, surgical neurological and psychological/psychiatric disorders.
•Participants who understand only Tamil language

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of functional outcome measured using,<br>1. Handheld Dynamometer (HHD) and Hip abductor strength<br>2. Single-Limb Mini Squat (SLMS): Assessment Procedures <br>3.Y Balance Test<br>Psychological status using, <br>4.GHQ 12 questionnaire<br>5. Pain status using, visual analogue scale for pain (100 mm VAS)<br><br> [1. Day 1 14, and 28<br>2. Day 1 and 28<br>3. Day 1 and 28<br>4. Day 1 and 28<br>5. Day 1,7,14,21 and 28]<br>
Secondary Outcome Measures
NameTimeMethod
one<br> []<br>
© Copyright 2025. All Rights Reserved by MedPath